This study explores how absorptive, innovative and adaptive capabilities within early project
phases affect project and portfolio performances in pharmaceutical and biotechnology R&D …

In recent years cell therapies have evolved and matured, moving from academia to industry.
Scale up of a process is the natural path of any product evolutionary development and …

In this study, we use both resource-based and institution-based theories to examine
potential sources of competitive advantage in the relatively new and rapidly growing …

We examine which factors determine the performance of strategic alliances as most
common strategy for technology commercialization in Iran biopharmaceutical industry. We …

The TERMIS-Europe (EU) Industry committee intended to address the two main critical
issues in the clinical/commercial translation of Advanced Therapeutic Medicine Products …

The optimal allocation of resources at the firm level to transform emergent technological
invention into commercially successful products depends on the effective assessment and …

Building a bioeconomy requires efficient technology transfer and global linkages to exploit
finite intellectual property exclusivity periods. Using a resource‐based view lens, this paper …

The focus of this paper is on the nexus between entrepreneurial learning and the innovation
process. In particular, the role that entrepreneurial learning plays in the innovation process …

Traditionally, firms in the pharmaceutical industry have depended on their internal research
and development (R&D) capabilities to maintain a productive new product pipeline. During …

In this paper, we draw on two studies that used face-to-face, qualitative interviews with
technology-based small firms (TBSFs) and informal interviews with key informants. The …